Two different smartwatches exhibit high accuracy in evaluating heart rate and peripheral oxygen saturation in cats when compared with the electrocardiography and transmittance pulse oximetry.

Objective: To evaluate the accuracy for 2 smartwatches with oximetry technology and optical wrist heart rate (HR) or single-lead Electrocardiography (ECG) technology (Fenix 5X Plus [GF5xp], Garmin Ltd and Apple Watch 6 [AppW6], Apple Inc, respectively) versus reference methods (ECG and transmittance pulse oximetry [TPO], respectively) in measuring HR and peripheral oxygen saturation of hemoglobin (SpO2) in cats.

Animals: 10 male client-owned cats aged 8 to 12 months and weighing 3.2 to 4.5 kg.

Procedures: All cats that were presented for elective castration at the Atatürk University Animal Hospital between March 10 and April 15, 2022, were considered for enrollment. Monitoring of HR and SpO2 during anesthesia was performed with a 3-lead ECG and transmittance pulse oximetry, respectively, connected to a multiparameter monitor (reference methods) along with a GF5xp and a AppW6. Agreement between reference methods and the smartwatches were assessed by the Bland-Altman plot, in which the differences (%) between methods were plotted against their mean HR or SpO2 (reference method measurement - test device measurement) and the limits of agreement (mean ± 1.96 × SD).

Results: Compared with ECG measurements of HR, GF5xp had superior bias (-0.1%) and limit of agreement (LoA, 3.0 to -3.3%) versus those of the AppW6 (bias, 0.2%; LoA, 3.7 to -3.4%). Compared with TPO measurements of SpO2, AppW6 had superior bias (0.2%) and LoA (3.0% and -2.5%) versus those of the GF5xp (bias, -2.1%; LoA, 0.2 to -4.4%).

Clinical Relevance: Results indicated that the GF5xp and AppW6 exhibited high accuracy in evaluating HR and SpO2 in cats when compared with the reference methods. However, it should be noted that these comparisons were made in anesthetized patients without any systemic disease.